Lower mean platelet volume predicts poor prognosis in renal cell carcinoma
Open Access
- 27 July 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 6700
Abstract
Altered mean platelet volume (MPV) is found in several malignancies. Remarkably, there is little consensus on using the value of MPV in the prognostic evaluations of renal cell carcinoma (RCC). The aim of this study is to examine the feasibility of MPV value as a prognostic indicator of RCC. The retrospective study recruited 306 consecutive RCC patients between January 2009 and December 2009. The relationships between MPV and clinicopathological characteristics were analyzed. Kaplan-Meier method and Cox regression were used to evaluate the prognostic impact of MPV. Of the 306 RCC patients, low MPV levels were detected in 61 (19.9%) patients. Reduced MPV was associated with histology types, T classification, UCLA Integrated Scoring System (UISS) category, and Mayo clinic stage, size, grade, and necrosis score (SSIGN) category (P < 0.05). Patients with decreased MPV had significantly shorter survival time than patients with normal MPV (P < 0.001). Cox regression analysis revealed that reduced MPV was an independent prognostic factor for overall survival (hazard ratio, 1.758; 95% confidence interval [CI], 1.083–2.855, P = 0.023). Moreover, the prognostic accuracy of TNM stage, UISS, and SSIGN prognostic models were improved when MPV was added. In conclusion, reduced MPV is identified as an independent predictor of adverse clinical outcome in RCC.Keywords
This publication has 26 references indexed in Scilit:
- Platelets in Tumor Progression: A Host Factor That Offers Multiple Potential Targets in the Treatment of CancerJournal of Cellular Physiology, 2014
- Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancerLung Cancer, 2014
- Low differentiated microvascular density and low expression of platelet‐derived growth factor‐ BB ( PDGF‐BB ) predict distant metastasis and poor prognosis in clear cell renal cell carcinomaBJU International, 2013
- Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancerJournal of Obstetrics and Gynaecology Research, 2012
- Cancer-related inflammationNature, 2008
- Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumorsInternational Journal of Laboratory Hematology, 2008
- Blocking Platelet-Derived Growth Factor-D/Platelet-Derived Growth Factor Receptor β Signaling Inhibits Human Renal Cell Carcinoma Progression in an Orthotopic Mouse ModelCancer Research, 2005
- Expression of Platelet-Derived Growth Factor-α Receptor Is Associated With Tumor Progression in Clear Cell Renal Cell CarcinomaAmerican Journal of Clinical Pathology, 2003
- Expression of Platelet-Derived Growth Factor-aa Receptor Is Associated With Tumor Progression in Clear Cell Renal Cell CarcinomaAmerican Journal of Clinical Pathology, 2003
- The significance of thymidine phosphorylase/platelet‐derived endothelial cell growth factor activity in renal cell carcinomaCancer, 2003